Date
8 Sep 2026
Time
14:00 – 17:10 (Registration opens at 13:45)
Venue
Deloitte HKSTP Office, 2/F, Building 16E, Phase 2, Hong Kong Science Park
Event Overview
Co-organised by HKSTP and Deloitte China, this exclusive seminar provides a roadmap from early-stage research to public listing for biotech companies navigating Chapter 18A. Gain actionable guidance from esteemed capital market practitioners, a leading biotech founder, and a seasoned VC investor on market timing, compliance, accounting, tax strategies, and securing growth capital.
- IPO Trends: Insights on the latest issuance landscape and issuing windows from Ms. Nelly Pai (J.P. Morgan).
- Listing Considerations: Regulatory focus, special rights termination, accounting updates, and pre-IPO tax implications from Mr. Conrad Chan (Kwok Yih & Chan), Mr. Ernest Lee (Deloitte China), and Ms. Shanice Siu (Deloitte China).
- VC/PE Financing & Growth: Pre-IPO preparation, valuation, and deep-tech financing strategies shared by Mr. Tom Lau (Yicura) and Mr. Fred Li (Gobi Partners).
(Programme is subject to change; final arrangements are subject to on-site confirmation.)
Date: Tuesday, September 8, 2026 | Time: 13:45 – 17:10 | Location: 2/F, Building 16E, Phase 2, Hong Kong Science Park
| Time | Agenda | Speaker / Guest Speaker |
|---|---|---|
| 13:45 – 14:00 | Guest Registration | |
| 14:00 – 14:05 | Welcome Remarks | Bong Chan - Southern Region TMT leader and lead partner of the Deloitte Hong Kong Science Park Office, Deloitte China |
| 14:05 – 14:10 | Introductory Remarks | Terry Wong - Chief Executive Officer, Hong Kong Science and Technology Parks Corporation (HKSTP) |
| 14:10 – 14:15 | Group Photo | All Attendees |
| Topic 1: Capital Markets | ||
| 14:15 – 14:45 |
Capital Market Dynamics - Recent IPO Issuance Landscape - Key Investor Insights - How to Choose an Issuance Window |
Nelly Pai - Managing Director, J.P. Morgan; Member of the Listing Committee, HKEX |
| Topic 2: Legal, Tax, and Accounting Considerations for Listing Regulations and BD Transactions | ||
| 14:45 – 15:15 |
Capital Market Regulations and Related Legal Matters - Key Regulatory Focus Areas of HKEX - Key Areas of Concern for the SFC - Arrangements and Impacts of the Termination of Special Rights |
Conrad Chan - Co-Founding Partner, Kwok Yih & Chan |
| 15:15 – 15:40 |
Latest Developments in Capital Market Regulations and Accounting Considerations for Listing - Latest Developments in Hong Kong Listing Rules - Key Regulatory Points for Listing Accounting |
Ernest Lee - Senior Technical Partner, Deloitte China |
| 15:40 – 16:05 |
Tax Considerations for Listing and BD Transactions - Tax Impacts of Shareholding Reform for Listing - Out-licensing and Collaborative Transactions - Introduction to Hong Kong Tax Incentives |
Shanice Siu - International Tax Partner, Deloitte China |
| 16:05 – 16:20 | Tea Break | |
| Topic 3: VC/PE Financing, Enterprise Growth, and Case Sharing | ||
| 16:20 – 16:40 |
Enterprise Case Sharing: Yicura BioMed Limited - From R&D to Clinical: Development Journey and Milestones - Science Park Ecosystem and Government Funding Schemes - The Road to Financing: Investor Communication and Valuation Considerations - Internal Preparations Before Listing and Experience Sharing |
Tom Lau - Deputy CEO and Co-founder, Yicura BioMed Limited |
| 16:40 – 17:00 | Deep Tech Startups – The Art and Strategy of Financing | Fred Li - Managing Director & Head of University Ventures, Gobi Partners |
| 17:00 – 17:05 | Q&A Session | |
| 17:05 – 17:10 | Closing Remarks | Polly Lee - Deputy National Managing Partner and Managing Partner of Southern Region, Audit & Assurance, Deloitte China |
*The agenda and timing are subject to change based on actual circumstances. On-site arrangements shall prevail.
